ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
63,724.89
-1.75%
S&P 500
5,631.22
0.28%
Dow Jones
40,211.72
0.53%
US Dollar vs Yen
158.4325
0.18%
Brent Oil
83.255
-1.29%
Registration Strip Icon for default 登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. NASDAQ
  6. Blueprint Medicines Corporation (BPMC)

  7. Blueprint Medicines Corporation (BPMC) ニュース

BPMC

Blueprint Medicines (BPMC)

Blueprint Medicines Corporation
から:
次の項目別のソート:
 Showing the most relevant articles for your search:NASDAQ:BPMC
日付受信時刻ニュースソース見出しコード企業名
2020/10/0605 : 17Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:BPMCBlueprint Medicines Corporation
2020/10/0605 : 16Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:BPMCBlueprint Medicines Corporation
2020/10/0305 : 01PR Newswire (US)Blueprint Medicines Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)NASDAQ:BPMCBlueprint Medicines Corporation
2020/09/2605 : 28Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:BPMCBlueprint Medicines Corporation
2020/09/2605 : 28Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:BPMCBlueprint Medicines Corporation
2020/09/2605 : 27Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:BPMCBlueprint Medicines Corporation
2020/09/2600 : 46PR Newswire (US)Blueprint Medicines Announces European Commission Approval of AYVAKYT® (avapritinib) for the Treatment of Adults with Unrese...NASDAQ:BPMCBlueprint Medicines Corporation
2020/09/2505 : 23Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:BPMCBlueprint Medicines Corporation
2020/09/2505 : 22Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:BPMCBlueprint Medicines Corporation
2020/09/2221 : 21Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:BPMCBlueprint Medicines Corporation
2020/09/2220 : 00PR Newswire (US)Blueprint Medicines Announces Positive Top-line Results from EXPLORER and PATHFINDER Trials of AYVAKIT™ (avapritinib) in Pa...NASDAQ:BPMCBlueprint Medicines Corporation
2020/09/2205 : 22Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:BPMCBlueprint Medicines Corporation
2020/09/2121 : 01Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:BPMCBlueprint Medicines Corporation
2020/09/2021 : 25PR Newswire (US)Blueprint Medicines Reports ARROW Trial Data at ESMO Virtual Congress 2020 Demonstrating Durable Clinical Benefits of GAVRETO...NASDAQ:BPMCBlueprint Medicines Corporation
2020/09/1721 : 00PR Newswire (US)Blueprint Medicines Presents Foundational Preclinical Data for BLU-945 Showing Robust Anti-Tumor Activity in Treatment-Resist...NASDAQ:BPMCBlueprint Medicines Corporation
2020/09/1005 : 01PR Newswire (US)Blueprint Medicines to Present at 18th Annual Morgan Stanley Global Healthcare ConferenceNASDAQ:BPMCBlueprint Medicines Corporation
2020/09/0508 : 00PR Newswire (US)Blueprint Medicines Announces FDA Approval of GAVRETO™ (pralsetinib) for the Treatment of Adults with Metastatic RET Fusion...NASDAQ:BPMCBlueprint Medicines Corporation
2020/09/0505 : 21Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:BPMCBlueprint Medicines Corporation
2020/09/0421 : 00PR Newswire (US)Blueprint Medicines Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)NASDAQ:BPMCBlueprint Medicines Corporation
2020/09/0121 : 29Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:BPMCBlueprint Medicines Corporation
2020/09/0121 : 00PR Newswire (US)Blueprint Medicines Strengthens Leadership with Appointment of Fouad Namouni, M.D., as President, Research & DevelopmentNASDAQ:BPMCBlueprint Medicines Corporation
2020/08/2205 : 23Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:BPMCBlueprint Medicines Corporation
2020/08/2005 : 52Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:BPMCBlueprint Medicines Corporation
2020/08/0421 : 00PR Newswire (US)Blueprint Medicines Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)NASDAQ:BPMCBlueprint Medicines Corporation
2020/08/0105 : 01Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:BPMCBlueprint Medicines Corporation
2020/07/3020 : 39Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:BPMCBlueprint Medicines Corporation
2020/07/3020 : 00PR Newswire (US)Blueprint Medicines Reports Second Quarter 2020 Financial ResultsNASDAQ:BPMCBlueprint Medicines Corporation
2020/07/2505 : 31Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:BPMCBlueprint Medicines Corporation
2020/07/2421 : 30PR Newswire (US)Blueprint Medicines Receives Positive CHMP Opinion for Avapritinib for the Treatment of Adults with Unresectable or Metastati...NASDAQ:BPMCBlueprint Medicines Corporation
2020/07/2321 : 00PR Newswire (US)Blueprint Medicines to Report Second Quarter 2020 Financial Results on Thursday, July 30, 2020NASDAQ:BPMCBlueprint Medicines Corporation
 Showing the most relevant articles for your search:NASDAQ:BPMC

最近閲覧した銘柄

CCOM
US100
US Tech 100
USI
USTECH100
US Tech 100
CCOM
US30
US 30
SPI
SP500
S&P 500
NYSE
NKE
Nike
AMEX
XLV
Health Care Select Sector
NASDAQ
QQQ
Invesco QQQ Trust Series 1
USOTC
BASFY
BASF (QX)
NYSE
DIS
Walt Disney
USOTC
ADDYY
Adidas (QX)
COIN
SOLUSD
Solana
NYSE
BAC
Bank of America
USOTC
RHHBY
Roche (QX)
USOTC
BNPQY
BNP Paribas (QX)
NASDAQ
NVDA
NVIDIA
AMEX
XLF
Financial Select Sector
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

日本
会社情報
ビジネス
人気
アプリを入手
App Store
Google Play

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有